2019 Prize Winners

 

 

ACP McElwain Prize

Dr Kroopa Joshi

 


AstraZeneca Young Scientist Poster Prize

A CRISPR/Cas9-mediated Screening of the F-box domain-containing E3 Ligase family in Intestinal Organoids

Hossein Kashfi, Cancer Genetic and Stem cell group, Division of cancer and stem cell, Nottingham University

 


British Association of Cancer Research (BACR) – AstraZeneca Young Scientist Frank Rose Award

3-D cell culture models for detection of biomarker indicating anti-EGFR antibody resistance in colon cancer patients

Nicola Valeri, The Institute for Cancer Research

 


British Association of Cancer Research (BACR) – Astex Pharmaceuticals Roger Griffin Prize for Cancer Drug Discovery

Liam Hudson, Global Discovery Chemistry, USA

 


British Association of Cancer Research (BACR) Chris Marshall Prize for Cell Signalling

Georgouli Mirella, King’s College London, UK

 


Children’s Cancer and Leukaemia Group (CCLG) Award

A high-throughput sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia

Eleanor WattUCL, London UK

Cancer Research Excellence in Surgical Trials (CREST) Award

The Endometrial Cancer Research Group, led by Professor of Gynaecological Oncology Emma Crosbie.


National Cancer Research Institute (NCRI) Bursary Prizes

The placebo response in trials of drug treatments for cancer-related fatigue: A systematic review, meta-analysis and meta-regression

Maria del Rocio Roji Buqueras, University College London, London, UK

Meat intake and cancer risk: prospective analyses in UK Biobank

Anika Knuppel, Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, UK

The p53/p21 axis suppresses 5FU-induced, ATM/ATR-STAT3-mediated activation of PD-L1 

Tamas Sessler, Centre for Cancer Research & Cell Biology Queen’s University Belfast, Belfast, UK

Investigating COX isoform dependency in intestinal tumourigenesis 

Noha-Ehssan Mohamed, Cancer Research UK Beatson Institute, Glasgow, UK
Camille Maringe, London School of Hygienen and Tropical Medicine, London, UK

National Cancer Research Institute (NCRI) Future of Research Bursaries 

A potent synergy between FOXG1 overexpression and Wnt signaling drives cell cycle re-entry in quiescent glioblastoma stem cells 

Faye Robertson, University of Edinburgh, Edinburgh, UK

Garth Funston, Department of Public Health and Primary Care, University of Cambridge, UK

Role of cholesterol in colon cancer and its impact on AOM/DSS induced mouse intestinal tumourigenesis

Shyamananda Singh Mayengbam ,Manoj Kumar Bhat, National Centre for Cell Science, Savitribai Phule Pune University, Pune, India

National Cancer Research Institute (NCRI) Werth Trust Award

Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (MBM; CheckMate 204)

Peter Forsyth, Moffitt Cancer Center and Research Institute, Tampa, US

Royal College of Radiologists (RCR) Ross Award Prize

Predicting risk of early relapse with circulating tumour DNA for advanced ER+ breast cancer patients in the PALOMA-3 trial 

Ben O’Leary, The Institute of Cancer Research